This replenishment seeks to raise at least $14 billion to help save 16 million lives, avert 234 million infections and help the world get back on track to end these diseases.
The Global Fund is calling on the private sector to mobilise at least $1 billion to step up the fight.
MedAccess has been invited to showcase how a social finance company can accelerate the delivery of new and better products in the fight against these diseases.
CEO Michael Anderson will join a panel discussion with pharmaceutical companies Sanofi and ViiV Healthcare.
Here, he will discuss how MedAccess guarantees will help to make quality health products more accessible at lower prices, enabling patients to live longer and healthier lives.
Michael will also announce a fresh injection of $100 million of paid-in capital from our parent company, CDC Group.
This capital will allow MedAccess to further its mission of bringing affordable and accessible health products to more people in a wider range of countries.
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.
Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world